Home/Filings/4/0001048477-23-000055
4//SEC Filing

Hardy Alexander 4

Accession 0001048477-23-000055

CIK 0001048477other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:13 PM ET

Size

8.2 KB

Accession

0001048477-23-000055

Insider Transaction Report

Form 4
Period: 2023-12-01
Hardy Alexander
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-12-01+68,03968,039 total
  • Award

    Common Stock

    2023-12-01+47,332115,371 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2023-12-01+150,529150,529 total
    Exercise: $92.42From: 2024-12-01Exp: 2033-11-30Common Stock (150,529 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted on December 1, 2023. Price not applicable.
  • [F2]Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0002001910

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:13 PM ET
Size
8.2 KB